Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q1 2014 · 10-Q
Revenue$115.00K$115.00K+4.5% vs Q1 2013 Net Income-$3.84M-$3.84MN/M vs Q1 2013 EPS Diluted-$0.19-$0.19N/M vs Q1 2013 Operating Income-$3,832,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,257,000N/M Margins · derivedOperating margin-3332.2%−1703.1 pt vs Q1 2013
Net margin-3342.6%−1384.4 pt vs Q1 2013
ended Oct 31, 2013 · filed Dec 12, 2013 · 42 d after period end